Anthem BCBSLow ImpactAdministrative
[Virginia] Lenalidomide is now available with end‑to‑end REMS support
Published May 3, 2026
AI Summary
Lenalidomide, a cancer medication, is now available with end-to-end Risk Evaluation and Mitigation Strategy (REMS) support in Virginia. This change provides enhanced support for the medication's safety monitoring requirements.
Action Required
Review current lenalidomide prescribing and billing processes to understand how the new end-to-end REMS support may impact patient care coordination and documentation requirements. Contact Anthem for specific details on how this REMS support affects billing procedures.
Plan Types
All Plans
States
VA
Specialties
oncology, hematology